• Thanks For Visiting
    Thanks For Visiting
  • Kilauea Volcano Video
    Kilauea Volcano Video
  • Memorial Day Parade
    Memorial Day Parade
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

Sat05262018

+ Larger Font | + Smaller Font

Consumer Daily Reports

Consumer News: FDA shames companies accused of blocking generic drug development

PhotoOn Thursday, the Food and Drug Administration (FDA) publicly called out companies charged with blocking the development of generic drugs. According to generic manufacturers, brand name manufacturers are responsible for countless hurdles that delay production and development of generic medication, and this list is designed to put an end to that.

“Today we’re making a public list of companies that have potentially been blocking access to the samples of their branded products,” said FDA Commissioner Scott Gottlieb. “We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and approval.”

To ensure that generic medications are safe for consumer use -- and identical to the brand name -- generic drug makers need brand name manufacturers to be on their team, as they need access to the brand name samples. The now-public list shows each complaint generic drug companies have made against the brand name companies.

Companies like Pfizer, GlaxoSmithKline, Novartis, and Valeant Pharmaceuticals -- just to name a few -- made the list of brand name companies that have been thwarting generic drug production. Additionally, Celegne topped the list with 13 complaints made against it to the FDA.

“No patients should be priced out of medicines they need to support their health,” Gottlieb said.

What this means for consumers

This move by the FDA comes after the White House released its plan to reduce drug prices for consumers. The plan, released last Friday, has four major goals: increasing competition, easing negotiation, creating incentives for lower prices, and lowering out-of-pocket spending on drugs.

The way the current system stands, drug companies have free reign to charge whatever they see fit for their products. With a new drug comes the ability to patent it; however, the FDA can also grant exclusivity to prevent competition in the market for certain periods of time. While drugmakers have various ways of doing this, their main tactic is to try to prevent competitors from creating copies.

“At times, certain ‘gaming tactics’ have been used to delay generic competition,” the FDA said in a statement. “One example of such gaming is when potential generic applicants are prevented from obtaining samples of certain brand products necessary to support approval of a generic drug. The inability of generic drug companies to purchase the samples they need slows down, or entirely impedes, the generic drug development process -- leading to delays in bringing affordable generic alternatives to patients in need.”

“This is a great day for for patients, since the administration’s list makes the definitive case why brand-name drug companies must stop blocking generic competition,” said Allen Goldberg, vice president of communications for the Association of Accessible Medicines.

There is currently legislation in the works that will aid in limiting what brand-name manufacturers can do to block generic competition. The CREATES Act has bipartisan support and will make it easier for generic manufacturers to sue for their right to provide consumers with cheaper copies of brand-name drugs. Despite support from both sides of the aisle, the bill is being held up amidst great opposition from drug companies.

“All the scheming and exploitation of our government’s rules means more profits for corporations at the expense of everyday Americans struggling to get the life-saving medicines they need,” said Tahir Amin, co-founder of Initiative for Medicines, Access & Knowledge.



Posted: 2018-05-18 11:44:34

Get Full News Story On Consumer Affairs


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Consumer News: FDA shames companies accused of blocking generic drug development | Consumer Daily Reports - Newscast

FDA shames companies accused of blocking generic drug development

Fri, 18 May 2018 04:50:00 GMT

On Thursday, the Food and Drug Administration (FDA) publicly called out companies charged with blocking the development of generic drugs. According to generic manufacturers, brand name manufacturers are responsible for countless hurdles that delay ...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 14:23:00 GMT

U.S. drug regulators are ... to ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of using a second strategy for blocking generics that FDA also is ...

Here are the pharma companies accused of blocking generic competition

Thu, 17 May 2018 11:07:00 GMT

But if the manufacturer creating the generic drug cannot get its hands on enough sample, the development and testing process slows down. It could potentially even keep a generic version of the drug from ever reaching the market. If companies developing ...

The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs

Thu, 17 May 2018 11:05:00 GMT

The Food and Drug ... been blocking access to the samples of their branded products,” said FDA Commissioner Scott Gottlieb in a statement. “We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development ...


Related Bing Web Search

FDA Names Drugmakers Accused Of Blocking Cheaper Generics

(Fri, 18 May 2018 19:39:00 GMT)

"We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and approval ... FDA Names Drugmakers Accused Of Blocking ...

FDA shames companies accused of blocking generic drug ...

(Thu, 17 May 2018 23:58:00 GMT)

Home / Finance / FDA shames companies accused of blocking generic drug development FDA shames companies accused of blocking generic drug development. Raquel Nash ...

FDA shames companies accused of blocking generic drug ...

(Fri, 18 May 2018 11:47:00 GMT)

The Food and Drug Administration has published a list of brand-name drug companies that have been accused of slowing the development of generic drugs.

FDA Names and Shames Drug Makers for Blocking Cheap ...

(Wed, 16 May 2018 23:52:00 GMT)

The FDA is publicly calling out drug makers like Celgene and Novartis accused ... Accused of Blocking Cheap Generic ... generic drug development ...

FDA Lists Companies Accused of Blocking Access to Drug ...

(Sat, 26 May 2018 02:05:00 GMT)

FDA Lists Companies Accused of Blocking Access to Drug Samples for ... securing samples of brand drugs for the purpose of generic drug development should ...

FDA names drugmakers accused of blocking cheaper generics

(Fri, 18 May 2018 16:05:00 GMT)

FDA names drugmakers accused of blocking cheaper ... "We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and ...

Here are the pharma companies accused of blocking generic ...

(Thu, 17 May 2018 18:08:00 GMT)

But if the manufacturer creating the generic drug cannot get its hands on enough sample, the development ... Here are the pharma companies accused of blocking generic ...

Stakeholders Take Aim at Generic Competition Blocking Tactics

(Wed, 24 Aug 2016 23:55:00 GMT)

Generic drug manufacturers have long accused their brand name counterparts of exploiting a federal program intended to promote medication safety as a means of blocking generic competition in the pharmaceutical marketplace.

FDA names drugmakers accused of blocking cheaper generics ...

(Thu, 17 May 2018 22:11:00 GMT)

FDA names drugmakers accused of blocking cheaper ... "We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and ...

FDA names drugmakers accused of blocking cheaper generics

(Thu, 17 May 2018 17:17:00 GMT)

FDA names drugmakers accused of blocking ... "We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and ...

Related News Story Videos From Youtube

FDA Publicly Accuses Drug Companies Of Trying To Block Generic Meds


Related Videos On: FDA Publicly Accuses Drug Companies Of Trying To Block Generic Meds


Obama Blocks Poor Nations' Access to Affordable Drugs


Related Videos On: Obama Blocks Poor Nations' Access to Affordable Drugs


Degeneracy | ContraPoints


Related Videos On: Degeneracy | ContraPoints


DaVita CEO Kent Thiry on Building a Signature Company Culture


Related Videos On: DaVita CEO Kent Thiry on Building a Signature Company Culture


Psychotropic Medications and Adverse Side Effects (58 min)


Related Videos On: Psychotropic Medications and Adverse Side Effects (58 min)






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
Copyright; 2008-2018 RobinsPost (The Bird's Eye View Company) All rights reserved.
News stories from trusted sources. RobinsPost.com provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by respective news sources.
ROBINSPOST.COM Is Proudly Made In America. - Where Quality, Safety and Service Comes First.